Cargando…

Atherosclerosis Development and Progression: The Role of Atherogenic Small, Dense LDL

Atherosclerosis is responsible for large cardiovascular mortality in many countries globally. It has been shown over the last decades that the reduction of atherosclerotic progression is a critical factor for preventing future cardiovascular events. Low-density lipoproteins (LDL) have been successfu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vekic, Jelena, Zeljkovic, Aleksandra, Cicero, Arrigo F. G., Janez, Andrej, Stoian, Anca Pantea, Sonmez, Alper, Rizzo, Manfredi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877621/ https://www.ncbi.nlm.nih.gov/pubmed/35208622 http://dx.doi.org/10.3390/medicina58020299

Ejemplares similares

Novel Pharmaceutical and Nutraceutical-Based Approaches for Cardiovascular Diseases Prevention Targeting Atherogenic Small Dense LDL
por: Vekic, Jelena, et al.
Publicado: (2022)

Lipoproteins and Cardiovascular Disease: An Update on the Clinical Significance of Atherogenic Small, Dense LDL and New Therapeutical Options
por: Rizvi, Ali A., et al.
Publicado: (2021)

A New Look at Novel Cardiovascular Risk Biomarkers: The Role of Atherogenic Lipoproteins and Innovative Antidiabetic Therapies
por: Vekic, Jelena, et al.
Publicado: (2022)

Oxidative Stress, Atherogenic Dyslipidemia, and Cardiovascular Risk
por: Vekic, Jelena, et al.
Publicado: (2023)

The Role of Advanced Glycation End Products on Dyslipidemia
por: Vekic, Jelena, et al.
Publicado: (2023)

Bergamot Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical Atherosclerosis in Subjects with Moderate Hypercholesterolemia: A 6 Months Prospective Study
por: Toth, Peter P., et al.
Publicado: (2016)

Pasta Supplemented with Opuntia ficus-indica Extract Improves Metabolic Parameters and Reduces Atherogenic Small Dense Low-Density Lipoproteins in Patients with Risk Factors for the Metabolic Syndrome: A Four-Week Intervention Study
por: Giglio, Rosaria Vincenza, et al.
Publicado: (2020)

Significance of LDL and HDL subclasses characterization in the assessment of risk for colorectal cancer development
por: Stevanovic, Milica, et al.
Publicado: (2018)

Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect
por: Nikolic, Dragana, et al.
Publicado: (2020)

Diabetes and Colorectal Cancer Risk: A New Look at Molecular Mechanisms and Potential Role of Novel Antidiabetic Agents
por: Vekic, Jelena, et al.
Publicado: (2021)

Association of Myeloperoxidase and the Atherogenic Index of Plasma in Children with End-Stage Renal Disease
por: Ristovski-Kornic, Danijela, et al.
Publicado: (2017)

Use of Novel Antidiabetic Agents in Patients with Type 2 Diabetes and COVID-19: A Critical Review
por: Popovic, Djordje S., et al.
Publicado: (2021)

Effect of Oral Semaglutide on Cardiovascular Parameters and Their Mechanisms in Patients with Type 2 Diabetes: Rationale and Design of the Semaglutide Anti-Atherosclerotic Mechanisms of Action Study (SAMAS)
por: Janić, Miodrag, et al.
Publicado: (2022)

Small Dense LDL Tied to Diabetic Retinopathy-Similarity to Atherosclerosis
por: Hirano, Tsutomu
Publicado: (2022)

Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?
por: Cicero, Arrigo F. G., et al.
Publicado: (2021)

Advances in the Pharmacological Management of Diabetic Nephropathy: A 2022 International Update
por: Giglio, Rosaria Vincenza, et al.
Publicado: (2023)

COVID-19 and diabetes management: What should be considered?
por: Ceriello, Antonio, et al.
Publicado: (2020)

The Effects of Sodium-Glucose Cotransporter 2-Inhibitors on Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease or Steatohepatitis and Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials
por: Bica, Ioana-Cristina, et al.
Publicado: (2023)

Metabolic Syndrome: From Molecular Mechanisms to Novel Therapies
por: Rizvi, Ali Abbas, et al.
Publicado: (2021)

Influence of Metabolic Syndrome on Small, Dense LDL, and Subclinical Atherosclerosis in Older Subjects
por: Yoshino, Hiroshi, et al.
Publicado: (2023)

Red Yeast Rice for the Improvement of Lipid Profiles in Mild-to-Moderate Hypercholesterolemia: A Narrative Review
por: Cicero, Arrigo F. G., et al.
Publicado: (2023)

Ezetimibe, cardiovascular risk and atherogenic dyslipidaemia
por: Rizzo, Manfredi, et al.
Publicado: (2011)

Effect of Semaglutide on Subclinical Atherosclerosis and Cardiometabolic Compensation: A Real-World Study in Patients with Type 2 Diabetes
por: Patti, Angelo Maria, et al.
Publicado: (2023)

Increased Small Dense LDL and Decreased Paraoxonase Enzyme Activity Reveals Formation of an Atherogenic Risk in Streptozotocin-Induced Diabetic Guinea Pigs
por: Aslan, Mutay, et al.
Publicado: (2013)

Endocrinology in the Time of COVID-19: A Rapid Evolution of Knowledge and Care
por: Rizvi, Ali A., et al.
Publicado: (2021)

An Update on the Current and Emerging Use of Thiazolidinediones for Type 2 Diabetes
por: Giglio, Rosaria Vincenza, et al.
Publicado: (2022)

Evaluation of different formulas for LDL-C calculation
por: Vujovic, Ana, et al.
Publicado: (2010)

Glucose Metabolism Disorders: Challenges and Opportunities for Diagnosis and Treatment
por: Vekic, Jelena, et al.
Publicado: (2022)

Prevalence of LDL atherogenic phenotype in patients with systemic lupus erythematosus
por: Olusi, Samuel O, et al.
Publicado: (2011)

Editorial: Diet-microbe-host interactions in metabolic syndrome
por: Gradisteanu Pircalabioru, Gratiela, et al.
Publicado: (2023)

A Critical View over the Newest Antidiabetic Molecules in Light of Efficacy—A Systematic Review and Meta-Analysis
por: Salmen, Teodor, et al.
Publicado: (2023)

Revealing the Role of High-Density Lipoprotein in Colorectal Cancer
por: Zeljkovic, Aleksandra, et al.
Publicado: (2021)

Electronegative LDL from Rabbits Fed with Atherogenic Diet Is Highly Proinflammatory
por: Chang, Po-Yuan, et al.
Publicado: (2019)

LDL-Cholesterol and Platelets: Insights into Their Interactions in Atherosclerosis
por: Gąsecka, Aleksandra, et al.
Publicado: (2021)

Hashimoto Thyroiditis and Dyslipidemia in Childhood: A Review
por: Vukovic, Rade, et al.
Publicado: (2019)

The Atherogenic Role of Circulating Modified Lipids in Atherosclerosis
por: Summerhill, Volha I., et al.
Publicado: (2019)

Effects of Gestational Diabetes Mellitus on Cholesterol Metabolism in Women with High-Risk Pregnancies: Possible Implications for Neonatal Outcome
por: Zeljković, Aleksandra, et al.
Publicado: (2022)

Liraglutide Improved Cardiometabolic Parameters More in Obese than in Non-obese Patients with Type 2 Diabetes: A Real-World 18-Month Prospective Study
por: Nikolic, Dragana, et al.
Publicado: (2022)

Amygdalin ameliorates the progression of atherosclerosis in LDL receptor-deficient mice
por: Lv, Jianzhen, et al.
Publicado: (2017)

Role of HDL function and LDL atherogenicity on cardiovascular risk: A comprehensive examination
por: Hernáez, Álvaro, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3h4t7p48pp39t5v981ji5g3lp1